TipRanks
Go Ultimate55% OFF

Adaptive Biotechnologies (ADPT) Cash flow

Adaptive Biotechnologies Cash Flow

ADPT's free cash flow for Q2 2026 was $-7.58M. For the 2026 fiscal year, ADPT's free cash flow was decreased by $-1.18M and operating cash flow was $-6.40M. See a summary of the company’s cash flow.

Cash Flow
Cash FlowDec 25Dec 24Dec 23Dec 22Dec 21
$ -45.99M$ -95.21M$ -156.32M$ -183.94M$ -192.73M
$ 37.95M$ 77.79M$ 129.65M$ 2.90M$ 181.21M
$ 30.40M$ 241.00K$ 2.25M$ 132.26M$ 27.15M
$ 73.18M$ 50.82M$ 65.06M$ 90.03M$ 139.06M
$ -48.95M$ -98.88M$ -167.02M$ -200.29M$ -254.47M

Currency in USD

Adaptive Biotechnologies Cash Flow

-600M-400M-200M0200M400M201720182019202020212022202320242025OperatingInvestingFinancing